자동 및 폐쇄형 세포 치료 시장

The global market for automated and closed cell therapy is expected to grow from $1.8 billion in 2024 and is projected to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.9% during the forecast period of 2024 to 2029.

The North American market for automated and closed cell therapy is expected to grow from $752.2 million in 2024 and is projected to reach $2.1 billion by the end of 2029, at a CAGR of 22.3% during the forecast period of 2024 to 2029.

The European market for automated and closed cell therapy is expected to grow from $539.1 million in 2024 and is projected to reach $1.5 billion by the end of 2029, at a CAGR of 22.9% during the forecast period of 2024 to 2029.

Report Scope:

The report highlights the current and future market potential of automated and closed cell therapy systems and a detailed analysis of the market drivers, restraints, and opportunities. The report also covers market projections for 2029, a competitive environment, patent, and product analysis. The report provides market estimates and forecasts for automated and closed cell therapy based on automation, cell type, application, and region. The market is segmented into CAR-T cells, stem cells, and other cell types based on cell type. The market is categorized as clinical and commercial based on the application type. The market is segmented into semi-automated and fully automated based on the type of automation. The semi-automated systems are further segmented based on workflow into apheresis, expansion, fill-finish, separation, and others. The report includes company profiles of the key industry players with detailed information about their business segments, financials, product portfolios, and recent developments. The report does not cover automated systems for basic operations such as pipetting or mixing.

By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Regional analysis is further broken down by country as follows: North America-the U.S., Canada, and Mexico; Europe-Germany, the U.K., France, Italy, Spain, and the Rest of Europe; Asia-Pacific-China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast through 2029.

Report Includes:

• 43 data tables and 46 additional tables
• An overview of the current and future global markets for automated and closed cell therapy
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024 and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts, with market share analysis based on the automation type, cell type, application, and region
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability and ESG trends, with emphasis on the ESG practices followed by leading companies, their ESG rankings and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
• Profiles of the leading companies, including Danaher Corp., Thermo Fischer Scientific Inc., Lonza, and Sartorius AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Overview
• Types of Cell Therapy
• Applications of Cell Therapy
• Regenerative Medicine
• Cancer
• Autoimmune Disorders

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Point-of-Care Manufacturing in CAR-T Therapies
• Growing Demand for Regenerative Medicine
• Market Restraints
• High Costs and Integration Challenges
• Regulatory Uncertainties
• Market Opportunities
• Increasing Startups in Cell Therapy Manufacturing
• Scalable Platforms

Chapter 4 Emerging Technologies and Developments

• Introduction
• Real-Time Monitoring (RTM) of Operations
• Off-the-Shelf Cell Therapies
• Miniaturization of Cell Therapy Systems

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Automated and Closed Cell Therapy Market by Automation Type
• Semi-Automated Cell Therapy
• Fully Automated Cell Therapy
• Global Automated and Closed Cell Therapy Market by Cell Type
• CAR-T Cells
• Stem Cells
• Other Cell Types
• Global Automated and Closed Cell Therapy Market by Application
• Market Size and Forecast
• Clinical
• Commercial
• Geographic Breakdown
• Global Market for Automated and Closed Cell Therapy by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 6 Competitive Intelligence

• Competitive Landscape
• Partnerships
• Investments and Funding
• Patent Analysis

Chapter 7 Sustainability in the Automated and Closed Cell Therapy Market

• Introduction
• Sustainability in the Automated and Closed Cell Therapy Industry
• Understanding the ESG Data
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• ADVA BIOTECHNOLOGY
• BIOSPHERIX LTD.
• CELLARES
• DANAHER CORP.
• FRESENIUS SE & CO. KGAA
• LONZA
• MILTENYI BIOTEC
• SARTORIUS AG
• TERUMO CORP.
• THERMO FISHER SCIENTIFIC INC.